Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemia. - Gardiner,N.; Lawler,M.; O'Riordan,J.M.; Duggan,C.; De-Arce,M.; McCann,S.R. (Bone Marrow Transplant, 1998)